Atomo Diagnostics Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AT1.AX research report →
Price Chart
About the company
Established in 2010 and based in Leichhardt, Australia, Atomo Diagnostics Limited is a global enterprise focused on the innovation and commercialization of medical devices. The company provides swift-result diagnostic tools designed for various applications, including COVID-19 detection, HIV screening, pregnancy confirmation, and assessing respiratory conditions.
- CEO
- John Michael Kelly
- IPO
- 2020
- Employees
- 85
- HQ
- Leichhardt, NSW, AU
Get TickerSpark's AI analysis on AT1.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $16.24M
- P/E
- -3.21
- PEG
- -0.06
- P/S
- 4.14
- P/B
- 2.17
- EV/EBITDA
- -3.11
- Div Yield
- 0.00%
- Gross Margin
- -9.92%
- Op Margin
- -118.09%
- Net Margin
- -101.45%
- ROE
- -58.40%
- ROIC
- -47.54%
Latest fiscal year · YoY change
- Revenue
- $3.79M-7.2%
- Gross Profit
- $1.79M+24.8%
- Op Income
- $-3,811,215
- Net Income
- $-4,970,934+27.4%
- EPS
- $-0.01+28.7%
- OCF Growth
- +58.2%
- FCF Growth
- +57.6%
- 52W High
- $0.05
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.03
- Beta
- 1.10
- RSI (14)
- 52
- Avg Volume
- 1.03M
No earnings-call transcripts are available for AT1.AX yet.
- Free Float
- 89.8%
- Shares Outstanding
- 902.43M
- Float Shares
- 810.59M
Our AT1.AX coverage
Recent articles, reports, and earnings notes.
No research on AT1.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AT1.AX report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.